Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination (NCT03209713)
🩺 Plain-English Summary (8th-Grade Level)
This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have extended the duration that participants are followed in assessing their child's uptake of the HPV vaccine to coincide with the COVID-19 related clinic closures and/or allow flexibility for participants who decide to delay their child's vaccination for fear of exposure to the COVID-19 infection. A survey will also assess the participants concerns regarding the impact COVID-19 has had in their daily life, such as financial insecurity, food access, housing insecurity and among other most common concerns during this unprecedented time. Additional navigation, referrals and interviewer notes will also be captured. Participants may be called by site or MSK staff to complete study surveys and will be informed verbally or by a mailed letter.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (2 items).
Location: Alivio Medical Center — Chicago, Illinois
Age range: 21 Years to 84 Years
🧪 Interventions in This Study
- HPV Vaccine Education (BEHAVIORAL)
- Text Messaging Reminder (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional's judgment.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (4 Sites)
- Alivio Medical Center — Chicago, Illinois
- Research, Education and Access to Community Health (REACH) — Las Vegas, Nevada
- Memorial Sloan Kettering Cancer Center — New York, New York
- The University of Texas at El Paso — El Paso, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parents
- Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation With Parents — Seattle, Washington
- Group CBT in Parents of Children With Food Allergy — Kansas City, Missouri
- Father-Inclusive Parenting Intervention in Mwanza, Tanzania — Atlanta, Georgia
- Text-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency — Nashville, Tennessee
- Resilient Families Feasibility Trial — Boston, Massachusetts
Explore by condition: All Parents clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.